Standard / prescription
Tirzepatide
Body Composition & Metabolic Support
Once-weekly dual GIP/GLP-1 medication for appetite, food-noise control, and glucose support.
Best use is body-fat reduction while protecting muscle with resistance training and high protein. This is a prescription drug; product labeling controls true dosing.
Dosage discussion lanes
- Starting / standard
- 2.5 mg once weekly for 4 weeks is the common label starting dose.
- Personal best / low-activity
- Often stay at 2.5–5 mg weekly longer if not very active; prioritize protein and hydration.
- Heavy trainer / athlete
- No separate “athlete dose”; heavy trainers usually protect performance by slow titration and higher protein. Maintenance label options include 5, 10, or 15 mg weekly when appropriate.
- Timing
- Same day weekly; any time of day.
- Cycle
- Often 12–24+ weeks when effective and tolerated; discontinue/taper only with a clinician plan.
- Men vs women
- Same principles; smaller users and many women titrate more slowly.
Watch-outs
GI upset, dehydration, constipation, reflux, gallbladder/pancreas history, hypoglycemia risk with diabetes meds.
Dose framework only. Do not convert to syringe units until product concentration and reconstitution volume are known. Adjust only with qualified oversight and side-effect tracking.
In our catalog
Educational and comparative only. Not a prescription, medical advice, or instruction to self-administer. Start low, change one variable at a time, and match the compound to the goal. Product formulation, route, concentration, lab work, medical history, medications, and legal/regulatory status change the plan.